US 11,969,405 B2
Method of treatment of topical dermatologic acne using a cream composition and method of manufacture
Dusan Sajic, Puslinch (CA); Maksym Breslavets, Toronto (CA); and Scottpatrick Sellitto, Buffalo, NY (US)
Assigned to Derma Research Group, Inc., Guelph (CA)
Filed by DERMA RESEARCH GROUP INC., Guelph (CA)
Filed on Sep. 1, 2022, as Appl. No. 17/901,688.
Application 17/901,688 is a continuation of application No. 16/742,595, filed on Jan. 14, 2020, abandoned.
Claims priority of provisional application 62/792,809, filed on Jan. 15, 2019.
Prior Publication US 2023/0055512 A1, Feb. 23, 2023
Int. Cl. A61K 31/327 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/045 (2006.01); A61K 31/05 (2006.01); A61K 31/095 (2006.01); A61K 31/145 (2006.01); A61K 31/194 (2006.01); A61K 31/25 (2006.01); A61K 31/455 (2006.01); A61K 31/65 (2006.01); A61K 31/7048 (2006.01); A61K 31/7056 (2006.01); A61K 33/30 (2006.01); A61K 36/185 (2006.01); A61K 36/58 (2006.01); A61K 36/61 (2006.01); A61K 36/74 (2006.01); A61K 36/82 (2006.01); A61K 47/34 (2017.01); A61P 17/10 (2006.01)
CPC A61K 31/327 (2013.01) [A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 31/045 (2013.01); A61K 31/05 (2013.01); A61K 31/095 (2013.01); A61K 31/145 (2013.01); A61K 31/194 (2013.01); A61K 31/25 (2013.01); A61K 31/455 (2013.01); A61K 31/65 (2013.01); A61K 31/7048 (2013.01); A61K 31/7056 (2013.01); A61K 33/30 (2013.01); A61K 36/185 (2013.01); A61K 36/58 (2013.01); A61K 36/61 (2013.01); A61K 36/74 (2013.01); A61K 36/82 (2013.01); A61K 47/34 (2013.01); A61P 17/10 (2018.01)] 21 Claims
OG exemplary drawing
 
1. A method of improving appearance of topical dermatologic acne skin, the method comprising:
identifying a target portion of skin that includes topical dermatologic acne;
providing a dermatologic acne treatment cream comprising a micro-encapsulated active ingredient and a skin revitalizing complex; wherein the micro-encapsulated active ingredient reduces inflammation, reduces oxidative free radicals, and decreases oxidative stress, and the skin revitalizing complex revitalizes and conditions the skin; wherein the micro-encapsulated active ingredient also functions to reduce inflammation and preventing pre-cancerous skin conditions, while the skin revitalizing complex assists in skin elasticity by boosting collagen production;
daily topical application of the dermatologic acne treatment cream, to the target portion of the skin for six weeks to allow the dermatologic acne treatment cream to noticeably reduce the topical dermatologic acne; and
continued daily topical application of the dermatologic acne treatment cream to the target portion of the skin to reduce a chance of reoccurrence of the topical dermatologic acne.